 | Up a level |
Kanwal, Khalid * and Lim, Hui Xuan * and Ayaz, Anwar * and Tan, Soon Hao and Hwang, Jung Shan * and Ong, Seng Kai * and Poh, Chit Laa * (2024) Preclinical Development of a Novel Epitope-based DNA Vaccine Candidate against SARS-CoV-2 and Evaluation of Immunogenicity in BALB/c Mice. AAPS PharmSciTech, 25 (3). ISSN 1530-9932
Yap, Wei Yuen * and Loo, Lok Wenn and Sha, Hong Xi and Hwang, Jung Shan * (2023) Enhanced production of recombinant HALT-1 pore-forming toxin using two-step chromatographic procedure. MethodsX, 10. ISSN 2215-0161
Yap, Wei Yuen * and Hwang, Jung Shan * (2023) Is Proteolytic Cleavage Essential for the Enhanced Activity of Hydra Pore-Forming Toxin, HALT-4? Toxins, 15 (6). ISSN 2072-6651
Looh, Sung Cheng and Soo, Zoey May Pheng and Wong, Jia Jia and Yam, Hok Chai and Chow, Sook Khuan and Hwang, Jung Shan * (2022) Aggregatibacter actinomycetemcomitans as the Aetiological Cause of Rheumatoid Arthritis: What Are the Unsolved Puzzles? Toxicon, 14 (1). ISSN 0041-0101
Sha, Hong Xi and Veerapen, Kumar and Chow, Sook Khuan * and Gun, Suk Chyn and Lau, Ing Soo and Lim, Renee Lay Hong and Zaliha, Zulkifli and Yow, Yoon Yen * and Peh, Suat Cheng * and Hwang, Jung Shan * (2022) Genetic variations in methotrexate metabolic pathway genes influence methotrexate responses in rheumatoid arthritis patients in Malaysia. Scientific Reports, 12. ISSN 2045-2322
Yap, Wei Yuen * and Hwang, Jung Shan * (2018) Response of cellular innate immunity to Cnidarian Pore-Forming toxins. Molecules, 23 (10). p. 2537. ISSN 1420-3049
Ameirika, . and Hong, Xi Sha and Hwang, Jung Shan * (2017) Identification of a target protein of Hydra actinoporin-like toxin-1 (HALT-1)using GST affinity purification and SILAC-based quantitative proteomics. Toxicon, 133. pp. 153-161. ISSN 0041 0101
Chow, Sook Khuan and Hwang, Jung Shan * (2024) Hope for arthritis patients. Star Media Group Berhad, The Star.
